Macromolecular prodrugs. XII. Primaquine conjugates: Synthesis and preliminary antimalarial evaluation

Acta Pharmaceutica

Volumn 59, Issue 1, 2009, Pages 107-115

  Rajić, Zrinka ^a   Kos, Gabrijela ^a   Zorc, Branka ^a   Singh, Prati Pal ^b   Singh, Savita ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Antimalarial activity; Glucosamine; Polyaspartamide; Polymer drug conjugate; Primaquine

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DRUG CARRIER; GLUCOSAMINE; POLYAMINOACID; POLYMER; POLY[ALPHA,BETA (N 2 HYDROXYETHYLASPARTAMIDE)]PRIMAQUINE CONJUGATE; POLY[ALPHA,BETA (N 3 HYDROXYPROPYLASPARTAMIDE)]PRIMAQUINE CONJUGATE; PRIMAQUINE DERIVATIVE; PRIMAQUINE GLUCOSAMINE CONJUGATE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONJUGATION; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; FEMALE; MACROMOLECULE; MALARIA; MALE; MOUSE; NONHUMAN; PLASMODIUM BERGHEI INFECTION; POLYMERIZATION; SWISS WEBSTER MOUSE;

EID: 62949126031     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0007-x     Document Type: Article

References (16)

1. S. Vangapandu, S. Sachdeva, M. Jain, S. Singh, P. P. Singh, C. L. Kaul and R. Jain, 8-Quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents, Bioorg. Med. Chem. 11 (2003) 4557-4568; DOI: 10.1016/j.bmc.2003.07.003.
2. N. Vale, R. Moreira and P. Gomes, Primaquine revisited six decades after its discovery, Eur. J. Med. Chem. (2008) (in press); DOI: 10.1016/j.ejmech.2008.08.011.
3. R. Jain, S. Jain, R. C. Gupta, N. Anand, G. P. Dutta and S. K. Puri, Synthesis of amino acid derivatives of 8-[(4-amino-1-methylbutyl)amino]-6- methoxy-4-substituted/4,5-disubstituted-quinolines as potential antimalarial agents, Ind. J. Chem. 33B (1994) 251-254.
4. M. Jain, S. Vangapandu, S. Sachdeva and R. Jain, Synthesis and blood-schizontocidal antimalarial activities of 2-substituted/2,5-disubstituted- 8-quinolinamines and some of their amino acid conjugates, Bioorg. Med. Chem. 12 (2004) 1003-1010; DOI 10.1016/j.bmc.2003.12.029.
5. R. Borissova, P. Stjärnkvist, M. O. Karlsson and I. Sjöholm, Biodegradable microspheres. 17. Lysosomal degradation of primaquine-peptide spacer arms, J. Pharm. Sci. 84 (1995) 256-262.
6. P. Stjärnkvist, Biodegradable microspheres: XIV. Effect of microparticle-bound primaquine on L. donovani in mice, Int. J. Pharm. 96 (1993) 23-32; DOI: 10.1016/0378-5173(93)90208-W.
7. A. Trouet, P. Pirson, R. Baurain and M. Masquelier, Cell Targeting of Primaquine, in Handbook of Experimental Pharmacology, Vol. 68, Part 2, Springer-Verlag, Berlin 1984, pp. 253-264.
8. R. Duncan, Polymer-drug Conjugates: Targeting Cancer, in Biomedical Aspects of Drug Targeting (Eds. V. Muzykantov and V. Torchilin), Kluwer Academic Publishers, Norwell 2002, pp. 193-209.
9. R. Duncan, The dawning era of polymer therapeutics, Drug Discovery 2 (2003) 347-360; DOI: 10.1038/nrd1088.
10. P. Mayorga, E. Deharo, F. Puisieux and G. Couarraze, Interpretation and prediction of plasma levels of primaquine following transdermal delivery in Swiss mice, Int. J. Pharm. 155 (1997) 99-107.
11. A. A. Date, M. D. Joshi and V. B. Patravale, Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles, Adv. Drug Deliv. Rev. 59 (2007) 505-521; DOI: 10.1016/j.addr.2007.04.009.
12. A. M. Dierling and Z. Cui, Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy, Int. J. Pharm. 303 (2005) 143-152; DOI: 10.1016/j.ijpharm.2005.07.015.
13. G. Džimbeg, B. Zorc, M. Kralj, K. Ester, K. Pavelić, J. Balzarini, E. De Clercq and M. Mintas, The novel primaquine derivatives of N-alkyl, cycloalkyl or aryl urea: synthesis, cytostatic and antiviral activity evaluations, Eur. J. Med. Chem. 43 (2008) 1180-1187; DOI: 10.1016/j.ejmech.2007.09.001.
14. J. Vlasák, F. Rypáček, J. Drobník and V. Saudek, Properties and reactivity of polysuccinimide, J. Polym. Sci. Polym. Symp. 66 (1979) 59-64.
15. M. Lovrek, B. Zorc, B. Boneschans and I. Butula, Macromolecular prodrugs. VIII. Polymer-gemfibrozil conjugates, Int. J. Pharm. 200 (2000) 59-66; DOI: 10.1016/S0378-5173(00)00340-9.
16. G. Antoni, C. Arezzini, F. Cocola, G. Gazzei and P. Neri, Pharmacological and toxicological evaluation of polyhydroxyethylaspartamide (PHEA) as a plasma substitute, Farmaco Ed. Pr. 34 (1979) 146-156.